Harte Hanks (HHS) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Completed a major sales transformation, centralizing and expanding the sales and marketing organization, and hiring a new Chief Customer and Data Officer to drive data and AI initiatives.
Successfully terminated Pension Plan I, resulting in a $38.2 million charge, a $10.1 million tax benefit, and $6.1 million cash contribution, with $1.3 million to be paid in Q3.
Project Elevate transformation program underway, targeting $16 million in cost savings by end of 2025, with $1.3 million in restructuring charges recorded YTD.
Segment realignment in 2024 separated Sales Services from Customer Care to enhance strategic focus.
Launched new products and secured a significant new marketing services account with a global automotive manufacturer.
Financial highlights
Q2 2024 revenue was $45.0 million, down 5.7% year-over-year from $47.8 million.
Operating income was $1.4 million, compared to $1.7 million in Q2 2023; adjusted operating income was $2.5 million versus $3.4 million.
Net loss of $27.8 million (or $3.84 per share), including $38.2 million pension termination charge and $10.1 million tax benefit; excluding these, net income would have been $0.3 million.
Adjusted EBITDA was $3.6 million, down from $4.4 million in Q2 2023.
Cash and cash equivalents at quarter-end were $11 million, with no debt and $24 million to $25 million available under the credit facility.
Outlook and guidance
Management expects improved revenues in the second half of 2024, assuming a supportive economy, with a robust sales pipeline and new business wins expected to contribute into 2025.
Project Elevate cost savings target of $16 million by end of 2025; 2024 savings expected to exceed $6 million.
Too early to predict sequential quarterly revenue improvement for Q3 or Q4, but Q4 typically benefits from seasonality and a stronger new business outlook.
Marketing services and international expansion, especially in Europe, are focal points for growth in 2025.
No substantial doubt about ability to continue as a going concern for the next twelve months.
Latest events from Harte Hanks
- Positive EBITDA and improved net results in FY 2025 despite lower revenue and segment declines.HHS
Q4 202518 Mar 2026 - Q3 revenue up 1.1% YoY; profit metrics declined; Q4 revenue expected to contract.HHS
Q3 202414 Jan 2026 - Shareholders to vote on board, executive pay, and auditor as company targets growth and innovation.HHS
Proxy Filing2 Dec 2025 - Beneficial ownership update adds Rosenbachs as 26.26% holders for 2025 meeting.HHS
Proxy Filing2 Dec 2025 - Q3 2025 revenue dropped 17% with net loss, but cost controls and new deals support outlook.HHS
Q3 202512 Nov 2025 - Revenue dropped 14.2% but net loss narrowed and EBITDA stayed positive in Q2 2025.HHS
Q2 20258 Aug 2025 - Revenue fell 8.6% to $41.6M, net loss widened, but liquidity and new business remain strong.HHS
Q1 20256 Jun 2025 - Net loss of $30.3M in 2024 driven by pension charges, despite improved cost structure.HHS
Q4 20245 Jun 2025